Insiders · NUVB

David Hung

President and CEO, Director, 10% owner at Nuvation Bio Inc. (NUVB) since February 2021

David Hung has filed 18 insider reports with the SEC since February 2021, as director at NovoCure Ltd (NVCR) and president and CEO, director and 10% owner at Nuvation Bio Inc. (NUVB). In the last 12 months David Hung sold $46.4K of stock on the open market. The latest filing, on June 5, 2026, reports grant or award at NovoCure Ltd (NVCR).

Filings
18
Companies
2
Bought on market
$1.71M
Sold on market
$63.7K

Companies where David Hung is an insider

CompanyRoleShares heldBoughtSoldAvg buyPrice nowLast filing
NovoCure Ltd logo
NVCR
NovoCure Ltd
Director32,075$63.7K$10.71Jun 5, 2026
Nuvation Bio Inc. logo
NUVB
Nuvation Bio Inc.
President and CEO, Director, 10% ownersince February 202159,281,054$1.71M$1.71$3.80+122%Mar 4, 2026

Shares held: common shares owned directly after the latest filing that states it. Avg buy: open-market purchase dollars divided by shares bought, every filing on record. Price now: the latest daily close, against the average buy price.

Every filing

Also sits on boards with

Officers and directors who share two or more companies with David Hung.

Compare David Hung with

Other insiders at the same companies

Questions about David Hung

What is David Hung's role at Nuvation Bio Inc.?
David Hung reports to the SEC as president and CEO, director and 10% owner at Nuvation Bio Inc. (NUVB), according to the latest filing on March 4, 2026. David Hung has also filed as director at NovoCure Ltd (NVCR).
How many shares does David Hung own?
After the latest filing that states it, David Hung directly owned 32,075 shares of NovoCure Ltd (NVCR) and 59,281,054 shares of Nuvation Bio Inc. (NUVB). Shares held through trusts, funds or family members are reported separately and are not counted here.
Has David Hung bought or sold stock recently?
The most recent open-market purchase was on June 16, 2025: bought 500,000 shares of Nuvation Bio Inc. (NUVB) for $894K at an average of $1.79. The most recent open-market sale was on June 2, 2026: sold 2,945 shares of NovoCure Ltd (NVCR) for $46.4K at an average of $15.77.
How do I get alerts when David Hung files?
Follow David Hung on Quantisnow and you get an email, and a phone notification on Plus, within minutes of each new Form 4 or Form 5, and of each Form 144 notice of a planned sale.

From SEC Forms 3, 4, 5 and 144 filed by David Hung (SEC CIK 0001310880). Totals count each trade once, skipping amendments whose original is on file, from Feb 12, 2021 on. View on SEC EDGAR · Get this as JSON